UPDATE: Gilead Sciences (GILD), Galapagos NV (GLPG) Report EMA Validates Marketing Application for Filgotinib for Treatment of Rheumatoid Arthritis

August 15, 2019 4:01 PM
(Updated - August 15, 2019 4:02 PM EDT)

Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (NASDAQ: GLPG) today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News FDA Management Comments

Next Articles